AW
DXCM icon

Alaethes Wealth’s DexCom DXCM Stock Holding History

Alaethes Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,496
Closed -$1.24M – 109
2024
Q3 		$1.24M Buy
18,496
+4,458
+32% +$366K 0.46% 86
2024
Q2 		$1.59M Buy
14,038
+93
+0.7% +$11.8K 0.66% 53
2024
Q1 		$1.93M Buy
13,945
+100
+0.7% +$12.6K 0.85% 41
2023
Q4 		$1.72M Buy
13,845
+57
+0.4% +$5.82K 0.81% 42
2023
Q3 		$1.29M Buy
13,788
+489
+4% +$55.1K 0.7% 58
2023
Q2 		$1.71M Sell
13,299
-50
-0.4% -$6.05K 0.94% 33
2023
Q1 		$1.55M Buy
13,349
+408
+3% +$45.7K 0.91% 34
2022
Q4 		$1.47M Buy
12,941
+27
+0.2% +$2.96K 1.01% 28
2022
Q3 		$1.04M Buy
12,914
+588
+5% +$49.8K 0.76% 51
2022
Q2 		$919K Buy
12,326
+918
+8% +$83.8K 0.68% 64
2022
Q1 		$1.46M Buy
11,408
+1,256
+12% +$137K 0.93% 29
2021
Q4 		$1.36M Buy
10,152
+816
+9% +$117K 0.86% 38
2021
Q3 		$1.28M Sell
9,336
-800
-8% -$101K 0.93% 35
2021
Q2 		$1.08M Buy
10,136
+916
+10% +$88K 0.84% 41
2021
Q1 		$828K Buy
+9,220
New +$865K 0.77% 51

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alaethes Wealth's DXCM Position: Q4 2024 in Review

Alaethes Wealth sold out of DexCom (DXCM) in Q4 2024, closing a stake of 18,496 shares — an estimated $1.24M sold.

Alaethes Wealth first reported a position in DXCM in Q1 2021 and held it in 15 quarters. The position peaked at $1.93M in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Alaethes Wealth reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Alaethes Wealth sold 18,496 DexCom shares in Q4 2024, an estimated $1.24M.
  • Alaethes Wealth first reported a position in DexCom in Q1 2021 and held it in 15 quarters.
  • Alaethes Wealth's DexCom position peaked at $1.93M in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Alaethes Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.